「for」の検索結果
119件：41～45件目を表示
-
CEO Message | About Senju | SENJU Pharmaceutical
Since Senju was established in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&a...
http://www.senju.co.jp/english/about/message.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
non-clinical ocular instillation toxicity studies of SJP-0132, a TRPV1 antagonist, a novel eye drop for dry eye disease Hideya Yonekura, Kotaro Yamada, Gen Suzuki, Yu Haranosono, Yoshinori Yamagiwa, I...
https://www.senju.co.jp/english/rd/society/ -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
Dry Eye Disease 1/2 SJP-0132 United States Completed NCT04139122 Disclaimer This website provides information on clinical trials sponsored by SENJU PHARMACEUTICAL Co., Ltd. (hereinafter referred to as...
http://www.senju.co.jp/english/rd/trial.html -
ral Announcement: February 20, 2025 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for BeelineMED” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribut...
https://www.senju.co.jp/system/files/content_news/2025-02/ENG_20250220_0.pdf -
Publications | Research & Development | SENJU Pharmaceutica
almology. 2026;283:163-175. VIEW PUBLICATION Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Pers...
http://www.senju.co.jp/english/rd/thesis/